Crossover Comparison of MultiHance and Dotarem

NCT02070380 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

179

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Disease

Interventions

DRUG: MultiHance 0.1 mmol/kg
DRUG: Dotarem
DRUG: MultiHance 0.05 mmol/kg

Sponsor

Bracco Diagnostics, Inc